2) May cause asthmatic attack. In the occurrence of initial symptom such as dry rale, strider, dyspnea, therapy should be discontinued. Asthmatic attack occur within hours after application.
3) Bleberosion, contact dermatitis such as irritation and swelling, dry skin and pigmentation may occur. Photosensitivity may occur with sunlight. Exanthem can be expanded systemically. In such severe case, therapy should be discontinued.
4) If any improvement is not shown after one month of therapy, it is discontinued and patients consult physician or pharmacist.
View ADR Monitoring Form